Capricor Therapeutics, Inc..
CAPR.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Capricor Therapeutics, Inc. is a biotechnology company focused on the discovery, development, and commercialization of novel cell and gene therapies for serious diseases. The company's lead product candidate is CAP-1002, an allogeneic cardiac-derived cell therapy, which is in clinical development fo...Show More
Better Health for All
0
No evidence available to assess Capricor Therapeutics, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess Capricor Therapeutics, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
The company's employee rating on Glassdoor is 3.7 out of 5 stars
1
, which translates to 74/100 for worker engagement. Multiple articles consistently state that no regulatory actions, violations, fines, or compliance issues related to labor laws or human rights are mentioned.
2
No specific quantitative data is available for living wage coverage, CEO to median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, turnover rate, insecure contract share, or health insurance coverage.
3
Fair Trade & Ethical Sourcing
0
No specific, concrete data points were found across the provided articles for any of the KPIs related to Fair Trade & Ethical Sourcing. The articles primarily discuss corporate governance, financial performance, clinical trials, and general ethical conduct for employees and agents, but do not provide quantitative or specific qualitative evidence regarding supplier fair trade certifications, audit frequencies, child/forced labor incidents, supply chain traceability, remediation speed, ethical clause coverage in supplier contracts, materials risk, or supplier diversity spend.
1
Information about the company's Code of Business Conduct and Ethics and compliance with laws like the FCPA pertains to internal employee conduct and general legal compliance, not specific ethical sourcing practices within the supply chain.
2
Honest & Fair Business
-40
The company has a formal whistleblower policy that prohibits retaliation against employees who report violations and protects confidentiality.
1
Its Audit Committee has adopted specific whistleblowing policies and procedures for accounting, internal accounting controls, fraud, or accounting matters.
2
However, there is no information on the frequency of training or the effectiveness of the program. The company states it conducts business in compliance with the FCPA and maintains policies and procedures to ensure continued compliance.
3
It also states its operations comply with Money Laundering Laws.
4
However, the Code of Business Conduct and Ethics indicates that certain small facilitation payments may be permissible if customary and approved by a principal financial officer,
5
and there is no information on training frequency or effectiveness metrics for its anti-corruption policy.
Kind to Animals
-70
Capricor Therapeutics conducts preclinical laboratory tests and animal studies, which are stated to be required by the FDA.
1
The company's job description for a Research Associate explicitly includes supporting in vivo drug potency studies and other animal-related tasks, confirming reliance on animal testing in murine and rabbit models.
2
There is no evidence of the company employing non-animal testing methods. The company's animal testing policy is not formally described in terms of reduction, prohibition, or oversight, only that animal testing is performed for medical analysis and clinical research.
3
No War, No Weapons
0
No evidence was found in the provided article to assess Capricor Therapeutics, Inc. against any of the KPIs for the 'No War, No Weapons' ethical value. The article details a company policy prohibiting individuals from possessing weapons on company property or during company business.
1
This is a workplace safety rule and does not provide information on the company's involvement in arms manufacturing, military contracts, dual-use technologies, or peacebuilding initiatives.
Planet-Friendly Business
-50
Capricor Therapeutics, Inc. maintains 100% compliance with EPA laboratory waste management regulations, indicating zero environmental compliance violations.
1
The company conducts an annual third-party environmental impact assessment.
2
Respect for Cultures & Communities
0
No evidence available to assess Capricor Therapeutics, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
-50
As of March 26, 2025, the company has not experienced a cybersecurity incident that has materially affected its business strategy, results of operations, or financial condition.
1
It has implemented a risk-based approach to identify and assess cybersecurity threats, conducting regular vulnerability scans and penetration tests.
2
The company is in the process of implementing a more formalized cybersecurity program and a cybersecurity oversight committee.
3
It states compliance with various privacy regulations including HIPAA, GDPR, CCPA, CPRA, and other state-specific acts.
4
However, the company's privacy policy indicates that users can only control their data by setting their browser to refuse cookies.
5
The company gathers broad demographic information using IP addresses, stored as a partial identifier, and does not provide details on data retention periods or minimization practices beyond this.
6
Zero Waste & Sustainable Products
-40
Capricor Therapeutics achieved a 30% reduction in plastic waste in 2023, eliminating 1,200 kg of plastic.
1
The company maintains 100% EPA compliance, indicating adherence to environmental regulations.
2
There have been no waste disposal violations reported in the past three years.
3
The company also holds an ISO 14001 certification for its Environmental Management System.
4